Posted inResearch
Thousands of clinical trial sites impacted by Middle East conflict: report
Nearly 8,000 clinical trial sites have been affected by the joint strikes on Iran by the U.S. and Israel and…
Posted inResearch
BMS links up with Faro to use AI to improve clinical trial protocols
Bristol Myers Squibb has tapped up Faro to use AI to improve the Big Pharma's clinical trial protocols. The multi-year…
Posted inResearch
Icon, Advarra partnership aims to optimize trials, expand access
Clinical research organization Icon has entered into a partnership with research technology company Advarra to launch a network of connected…
Posted inResearch
Syneos Health scoops up Chinese CRO to secure place in ‘rapidly growing market’
North Carolina-based contract research organization Syneos Health is making a play to capitalize on China’s rapidly ascendant biopharma industry. Syneos…
Posted inResearch
Agilent to acquire Biocare in $950M ‘complementary combination’
Bay Area laboratory solutions company Agilent Technologies has agreed to acquire Biocare Medical, a pathology solutions business, in an all-cash…
Posted inResearch
UK invests $64M to expand clinical trial access to underserved communities
In an effort to boost global biopharma competitiveness, the U.K.’s National Institute for Health and Care Research (NIHR) has awarded…
Posted inResearch
Charles River sells manufacturing and discovery businesses to fulfill promised pivot
After promising to sell off 7% of its business back in November, Charles River Laboratories has delivered. The CRO is…
Posted inResearch
Evinova reels in AI clinical development deals with Astellas and AstraZeneca
Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by deploying Evinova’s AI-native platform in an effort to speed up…
Posted inResearch
Immunology CRO RoukenBio pens pact with AVS Bio for more predictable antibody development
Preclinical CRO RoukenBio has inked a partnership with Connecticut-based biologics discovery specialist AVS Bio that aims to leverage each others'…
Posted inResearch
Icon shares plummet after CRO reveals accounting investigation, pulls 2025 guidance
Irish CRO Icon has revoked its 2025 financial guidance and launched an internal investigation after being made aware of possible…